Bd reaches major milestone for rotarex™ catheter system with first patient enrolled in xtract™ registry to advance real-world evidence in peripheral artery disease

Franklin lakes, n.j. , oct. 9, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced the enrollment of the first patient in the xtract™ registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the rotarex™ catheter system in the treatment of patients with peripheral artery disease (pad) lesions.
BDX Ratings Summary
BDX Quant Ranking